Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Aug 11, 2017 · 10-Q · 42 days after period end · 0001640334-17-001627
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$702.76K | $573.09K | -$2.06M | -$142.92K |
| EPS Diluted | -$0.02 | $0.03 | -$0.13 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end
